Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neuropsychobiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 11174046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

  1999cited by this paper
• Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

  1999cited by this paper
• Cytokines and depression: fortuitous or causative association?

  1999cited by this paper
• Olfactory Bulbectomy Provokes a Suppression of Interleukin-1β and Tumour Necrosis Factor-α Production in Response to an in vivo Challenge with Lipopolysaccharide: Effect of Chronic Desipramine Treatment

  1999cited by this paper
• Cerebrospinal Cytokine Levels in Patients with Acute Depression

  1999cited by this paper
• Fatigue and its associated factors in ambulatory cancer patients: a preliminary study.

  1999cited by this paper
• Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

  1999cited by this paper
• Aberrant interleukin-2 receptor-mediated blastoformation of peripheral blood lymphocytes in a severe major depressive episode

  1998cited by this paper
• Blood levels of cytokines in elderly patients with major depressive disorder

  1998cited by this paper
• Cytokine Production and Serum Proteins in Depression

  1995cited by this paper
• Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.

  1995cited by this paper
• Cytokine production in major depressed patients before and after clomipramine treatment.

  1994cited by this paper
• The effects of prolonged lithium exposure on the immune system of normal control subjects: serial serum soluble interleukin-2 receptor and antithyroid antibody measurements.

  1994cited by this paper
• Increased soluble interleukin‐2 receptor concentrations in suicide attempters

  1993cited by this paper
• Biological significance of soluble IL-2 receptor

  1993cited by this paper
• Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

  1993cited by this paper
• Low natural killer cytotoxicity in major depression.

  1987cited by this paper
• Lymphocyte function in major depressive disorder.

  1984cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Beyond Conventional Treatments: The Role of Complementary Therapies in Head and Neck Cancer

  2025cites this paper
• The effect of Vortioxetine on the NLRP3 pathway and microglial activity in the prefrontal cortex in an experimental model of depression

  2024cites this paper
• The Neurodegenerative Hypothesis of Depression and the Influence of Antidepressant Medications.

  2024cites this paper
• Breaking free from the inflammatory trap of depression: Regulating the interplay between immune activation and plasticity to foster mental health

  2023cites this paper
• Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression

  2023cites this paper
• A Review of the Role of Interleukin-2 in the Pathophysiology of Major Depressive Disorder in Hospitalized Patients

  2021cites this paper
• TNF-α Increase in a Cohort of Depressive Patients

  2021cites this paper
• Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population

  2021cites this paper
• Increased telomerase activity in major depressive disorder with melancholic features: Possible role of pro-inflammatory cytokines and the brain-derived neurotrophic factor

  2021cites this paper
• Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials

  2021cites this paper
• Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls

  2020cites this paper
• The cytokine network in the pathogenesis of major depressive disorder. Close to translation?

  2020cites this paper
• Multimodal Psychotherapeutic Inpatient Therapy of Depression Is Successful in Patients With High Cytokine Production

  2020cites this paper
• Brain-immune crosstalk in the treatment of major depressive disorder.

  2020cites this paper
• The interplay between depression and tuberculosis

  2019cites this paper
• Glucocorticoid receptor dysfunction orchestrates inflammasome effects on chronic obstructive pulmonary disease-induced depression: A potential mechanism underlying the cross talk between lung and brain.

  2019cites this paper
• Vortioxetine exerts anti‐inflammatory and immunomodulatory effects on human monocytes/macrophages

  2018cites this paper
• Origen y consecuencias de la inflamación en depresión

  2017influential citation
• Depression and inflammation: Pathophysiology and therapeutic implications

  2016cites this paper
• Interleukin‐1 β‐targeted treatment strategies in inflammatory depression: toward personalized care

  2016cites this paper
• Molecular Neurobiology and Promising New Treatment in Depression

  2016cites this paper
• Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment.

  2016cites this paper
• A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression

  2016cites this paper
• Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.

  2016cites this paper
• Inflammatory cytokine-associated depression.

  2015cites this paper
• Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder

  2015cites this paper
• Comorbidity between depression and asthma via immune-inflammatory pathways: a meta-analysis.

  2014cites this paper
• Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats.

  2014cites this paper
• Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone.

  2014cites this paper
• Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α.

  2013cites this paper
• Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.

  2013cites this paper
• Relations of depressive symptoms and antidepressant use to body mass index and selected biomarkers for diabetes and cardiovascular disease.

  2013cites this paper
• Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

  2013cites this paper
• Relationship between Depression and Proinflammatory Cytokine Levels in Hemodialysis Patients

  2012cites this paper
• Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder

  2012cites this paper
• Effects of sleep deprivation on nocturnal cytokine concentrations in depressed patients and healthy control subjects.

  2012cites this paper
• Inflammatory cytokines, growth factors, and depression.

  2012cites this paper
• Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis

  2012cites this paper
• Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depression.

  2012cites this paper
• Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.

  2012cites this paper
• Inflammation in psychotic disorders: a population-based study.

  2011cites this paper
• Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation

  2011cites this paper
• Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression.

  2011cites this paper
• Interleukin-1beta Promoter (−31T/C and −511C/T) Polymorphisms in Major Recurrent Depression

  2011cites this paper
• Cytokine Production by Leukocytes of Military Personnel with Depressive Symptoms after Deployment to a Combat-Zone: A Prospective, Longitudinal Study

  2011cites this paper
• The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis

  2011cites this paper
• The inflammation hypothesis in geriatric depression

  2011cites this paper
• Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression.

  2011cites this paper
• A psychoneuroimmunological review on cytokines involved in antidepressant treatment response

  2010cites this paper
• A meta-analysis of cytokines in major depression.

  2010cites this paper
• Lower serum levels of interleukin-6 in a population sample with symptoms of depression than in a population sample without symptoms of depression.

  2010cites this paper
• Meta-analysis of Plasma Interleukine-6 Levels in Patients with Depressive Disorder

  2010cites this paper
• Soluble interleukin-2 receptor and tumor necrosis factor levels in depressed patients in Estonia.

  2009cites this paper
• Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

  2009cites this paper
• ICV vs. VMH injection of leptin: comparative effects on hypothalamic gene expression.

  2009cites this paper
• Immune markers in major depression and in antidepressive treatment

  2009cites this paper
• The role of IL-2 and soluble IL-2R in depression and antidepressant response.

  2009cites this paper
• Curcumin and cancer: an "old-age" disease with an "age-old" solution.

  2008cites this paper
• Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression

  2008cites this paper
• Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

  2008cites this paper
• An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment.

  2007cites this paper
• The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

  2007cites this paper
• Impact of depression and its treatment on the bones of growing children

  2007cites this paper
• [Brain-immune interactions and implications in psychiatric disorders].

  2007cites this paper
• Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression.

  2007cites this paper
• Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder.

  2006cites this paper
• Biomarkers of depression in cancer patients

  2006cites this paper
• Interleukin-6 production and deregulation of the hypothalamic-pituitary-adrenal axis in patients with major depressive disorders

  2006cites this paper
• IL‐6 levels decrease with SSRI treatment in patients with major depression

  2005cites this paper
• Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures.

  2005cites this paper
• Amitriptyline and nortriptyline inhibit interleukin-1 b and tumour necrosis factor- a release by rat mixed glial and microglial cell cultures

  2005cites this paper
• Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia.

  2005cites this paper
• Interleukin-6 Genetic Polymorphism and Chinese Major Depression

  2005cites this paper
• Chai-hu-gui-zhi-gan-jiang-tang regulates plasma interleukin-6 and soluble interleukin-6 receptor concentrations and improves depressed mood in climacteric women with insomnia.

  2005cites this paper
• An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission.

  2005cites this paper
• Clinical efficacy of EH0202, a Kampo formula, on the health of middle-aged women.

  2004cites this paper
• Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder.

  2004cites this paper
• Changes in serum tumor necrosis factor (TNF-alpha) with kami-shoyo-san administration in depressed climacteric patients.

  2004cites this paper
• Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression.

  2004cites this paper
• Clinical Efficacy of EH 0202 , a Kampo Formula , on the Health of Middle-Aged Women

  2004cites this paper
• Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.

  2004cites this paper
• High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder.

  2003cites this paper
• The Relation of Severity of Depressive Symptoms to Monocyte-Associated Proinflammatory Cytokines and Chemokines in Apparently Healthy Men

  2003influential citation
• Behavioral and biochemical studies on chronic mild stress models in rats treated with a Chinese traditional prescription Banxia-houpu decoction.

  2003cites this paper
• The Immune State of Bulbectomized Mice

  2003cites this paper
• Association Study of the Interleukin-1beta (C-511T) Genetic Polymorphism with Major Depressive Disorder, Associated Symptomatology, and Antidepressant Response

  2003cites this paper
• Tumor necrosis factor‐β gene polymorphism may not be associated with major depressive disorder in the Korean population

  2003cites this paper
• Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults.

  2003cites this paper
• Possible association between –G308A tumour necrosis factor-&agr; gene polymorphism and major depressive disorder in the Korean population

  2003cites this paper
• Cytokines and depression: an analogic approach.

  2002cites this paper
• Antidepressant drugs and cytokines in mood disorders.

  2002cites this paper
• Elevated plasma interleukin‐6 (IL‐6) and soluble IL‐6 receptor concentrations in menopausal women with and without depression

  2002cites this paper
• Cumulative meta-analysis of interleukins 6 and 1 beta , tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder

  year unknowninfluential citation